Medical Marijuana Genetics: Medical Breeding

Founded in 2014, Medical Marijuana Genetics is dedicated to producing high-quality cannabis strains with therapeutic benefits. The company was created by a group of individuals who witnessed the healing properties of cannabis first-hand while treating their mother's late-stage pancreatic cancer.

Medical Marijuana Genetics - Developing CBD-Dominant Cannabis Strains

Medical Marijuana Genetics works with award-winning breeders to develop a range of CBD-dominant cannabis strains. Their first strain, Candida-CD1, has a CBD to THC ratio of 20:1, with a CBD content of 20%, making it one of the highest CBD-rich phenotypes in Europe.

Since then, the company has created 12 elite strains of Candida crosses, all genetically selected to offer the broadest therapeutics the cannabis plant and CBD have to offer. These strains can treat symptoms like chronic pain, inflammation, seizures, cramps, gastrointestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth, and much more.

Researching New Cannabinoids and Terpenoids

Medical Marijuana Genetics is continually researching to create new strains that contain other beneficial cannabinoids and terpenoids. Currently, all of their strains are CBD-dominant or CBD-rich (1:1), with at least 10% CBD content.

As one of the leading seed banks in the industry, Medical Marijuana Genetics encourages legally permitted customers to cultivate and publish laboratory results on the cannabis they produce.

Choose Medical Marijuana Genetics for high-quality cannabis strains with therapeutic benefits.